These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7515916)

  • 1. Transforming growth factor-beta 1 mediates mast cell chemotaxis.
    Gruber BL; Marchese MJ; Kew RR
    J Immunol; 1994 Jun; 152(12):5860-7. PubMed ID: 7515916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation.
    Mekori YA; Metcalfe DD
    J Immunol; 1994 Sep; 153(5):2194-203. PubMed ID: 7519644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta.
    Brandes ME; Mai UE; Ohura K; Wahl SM
    J Immunol; 1991 Sep; 147(5):1600-6. PubMed ID: 1652608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal mucosal immunoexpression of the mast cell chemoattractants TGF-beta, eotaxin, and stem cell factor and their receptors in allergic rhinitis.
    Salib RJ; Kumar S; Wilson SJ; Howarth PH
    J Allergy Clin Immunol; 2004 Oct; 114(4):799-806. PubMed ID: 15480318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotaxis of skeletal muscle satellite cells.
    Bischoff R
    Dev Dyn; 1997 Apr; 208(4):505-15. PubMed ID: 9097022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotactic response of osteoblastlike cells to transforming growth factor beta.
    Pfeilschifter J; Wolf O; Naumann A; Minne HW; Mundy GR; Ziegler R
    J Bone Miner Res; 1990 Aug; 5(8):825-30. PubMed ID: 2239366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel use of the human nasal epithelial cell line RPMI 2650 as an in vitro model to study the influence of allergens and cytokines on transforming growth factor-beta gene expression and protein release.
    Salib RJ; Lau LC; Howarth PH
    Clin Exp Allergy; 2005 Jun; 35(6):811-9. PubMed ID: 15969674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell factor is a chemotactic factor for human mast cells.
    Nilsson G; Butterfield JH; Nilsson K; Siegbahn A
    J Immunol; 1994 Oct; 153(8):3717-23. PubMed ID: 7523504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta1 inhibits late-stage mast cell maturation.
    Kashyap M; Bailey DP; Gomez G; Rivera J; Huff TF; Ryan JJ
    Exp Hematol; 2005 Nov; 33(11):1281-91. PubMed ID: 16263412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-β1 promotes nasal mucosal mast cell chemotaxis in murine experimental allergic rhinitis.
    Ouyang Y; Nakao A; Han D; Zhang L
    ORL J Otorhinolaryngol Relat Spec; 2012; 74(3):117-23. PubMed ID: 22433901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells display natural suppressor activity partially by releasing transforming growth factor-beta.
    Hu ZQ; Yamazaki T; Cai Z; Yoshida T; Shimamura T
    Immunology; 1994 Jul; 82(3):482-6. PubMed ID: 7959885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mast cell migration in response to members of the transforming growth factor-beta family.
    Olsson N; Piek E; ten Dijke P; Nilsson G
    J Leukoc Biol; 2000 Mar; 67(3):350-6. PubMed ID: 10733095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine mast cells express two types of C1q receptors that are involved in the induction of chemotaxis and chemokinesis.
    Ghebrehiwet B; Kew RR; Gruber BL; Marchese MJ; Peerschke EI; Reid KB
    J Immunol; 1995 Sep; 155(5):2614-9. PubMed ID: 7650391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal TGF-beta1 mediates IL-9/mast cell interaction and exacerbates excitotoxicity in newborn mice.
    Mesplès B; Fontaine RH; Lelièvre V; Launay JM; Gressens P
    Neurobiol Dis; 2005 Feb; 18(1):193-205. PubMed ID: 15649710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
    Joyce NC; Harris DL; Mello DM
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of mouse mast cell protease-6 gene by transforming growth factor-beta and activin in mast cell progenitors.
    Funaba M; Ikeda T; Murakami M; Ogawa K; Abe M
    Cell Signal; 2005 Jan; 17(1):121-8. PubMed ID: 15451032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteogenic protein-1, a bone morphogenic protein member of the TGF-beta superfamily, shares chemotactic but not fibrogenic properties with TGF-beta.
    Postlethwaite AE; Raghow R; Stricklin G; Ballou L; Sampath TK
    J Cell Physiol; 1994 Dec; 161(3):562-70. PubMed ID: 7962137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoattraction of neutrophils by substance P and transforming growth factor-beta 1 is inadequately explained by current models of lipid remodeling.
    Haines KA; Kolasinski SL; Cronstein BN; Reibman J; Gold LI; Weissmann G
    J Immunol; 1993 Aug; 151(3):1491-9. PubMed ID: 7687633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-3 affects endothelial cell-mediated smooth muscle cell recruitment by increasing TGF beta activity: potential role in tumor vessel stabilization.
    Dentelli P; Rosso A; Calvi C; Ghiringhello B; Garbarino G; Camussi G; Pegoraro L; Brizzi MF
    Oncogene; 2004 Mar; 23(9):1681-92. PubMed ID: 14755254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.